Carbonic anhydrase 2 (CA2) plays vital role in the regulation of ion transport and pH balance and is involved in many biological processes; however, its role in cancer remains obscure. In this study, we identified a novel function of CA2 in facilitating hepatocellular carcinoma (HCC) metastasis. CA2 expression was elevated in Na + -K + -ATPase α1 (ATP1A1)-downregulated HCC cells and was inversely correlated with that of ATP1A1 in HCC. ATP1A1 acted as an oncoprotein whereas CA2 overexpression inhibited cell migration and invasion by reversing epithelial-mesenchymal transition (EMT) in HCC. CA2 downregulation promoted HCC metastasis and invasion whereas ATP1A1 downregulation inhibited HCC metastasis. Because of the opposing effects of CA2 and ATP1A1 in HCC, we examined the role of their correlation in HCC metastasis. CA2 attenuated ATP1A1-triggered tumor growth in vivo and ATP1A1-induced metastasis in vitro. Taken together, the present results suggest that CA2 serves as a suppressor of HCC metastasis and EMT and is correlated with favorable overall survival (OS) in HCC patients.
Introduction
Hepatocellular carcinoma (HCC) is one of most frequent causes of cancer-associated mortality worldwide (1) . Despite the development of specific treatment strategies, the prognosis of HCC remains dismal. The outcomes of HCC patients are far from satisfactory even in patients who are eligible for surgical resection because of the occult nature of the disease and high metastatic potential (2) . Therefore, identification of metastasis-associated biomarkers is of vital importance for the prognosis and treatment of HCC.
Carbonic anhydrase 2 (CA2), which belongs to the carbonic anhydrase (CA) family, is involved in the reversible hydrationdehydration of carbon dioxide. Abnormal expression of CA2 is associated with many diseases, including cardiomyocyte hypertrophy and autoimmune diseases (3) (4) (5) (6) . However, information on its function in tumors is limited. Na + -K + -ATPase (NKA), which is an ion transport pump, is essential for maintaining the homeostasis of Na + and K + and cell physiology. It consists of three polypeptides, namely the α and β subunits and the FXYD proteins (7, 8) . Four α and four β subunits have been identified to date (9) . The α1 subunit of NKA is overexpressed in many tumors including esophageal squamous cell carcinoma and glioblastoma (10, 11) . Our previous study showed that CA2 was upregulated in ATP1A1-downregulated HCC cells (12) . In the current study, their inverse relationship was confirmed in HCC.
In this study, we showed that CA2 inhibited tumorigenesis and metastasis in HCC whereas ATP1A1 acted as an oncoprotein in HCC. We further investigated the involvement of CA2 in ATP1A1-induced HCC metastasis. Rescue experiments demonstrated that CA2 reversed ATP1A1-triggered tumor growth and metastasis. Here, we showed for the first time that CA2 inhibits epithelial-mesenchymal transition (EMT) in HCC and revealed the involvement of CA2 in ATP1A1-induced HCC metastasis. We also demonstrated an inverse relationship between ATP1A1 and CA2 in HCC. Altogether, we indicate that CA2 inhibits invasion and metastasis by suppressing EMT and serves as a prognostic marker in HCC.
Materials and methods

Cell lines and culture conditions
Huh7 and SMMC-7721were used in this study. Their The P value was calculated using a log-rank test. All experiments were performed three times and representative data are shown.
under pathogen-free conditions. All animals received humane care according to the principles described in the 'Guide for the Care and Use of Laboratory Animals' issued by the National Institutes of Health. The animals were allocated randomizedly. All experiments conformed to the ethical principles of the Animal Experimentation stipulated by Fudan University.
Patients and follow-up
For tissue microarray (TMA) studies, HCC samples were obtained from 74 patients who underwent hepatectomy at Fudan University Shanghai Cancer Center. The detailed information are described in the Supplementary Materials and Methods, available at Carcinogenesis Online. Use of human samples was approved by the Ethics Committee of Fudan University Shanghai Cancer Center (Shanghai, China), and informed consent was obtained from every patient.
Lentivirus construction and cell transfection
The shRNA-ATP1A1 lentiviral vectors were purchased from Hanyin Biotechnology Limited Company. The target sequences are described in the Supplementary Materials and Methods, available at Carcinogenesis Online.
Lentivirus infection
The detailed information on lentivirus infection was described in the Supplementary Materials and Methods, available at Carcinogenesis Online.
Cell proliferation, migration and Matrigel invasion assays
Cell proliferation, migration and Matrigel invasion assays were described in Supplementary Materials and Methods, available at Carcinogenesis Online.
Colony formation assay
Cell formation assay was conducted using gentian violet (Solarbio). Detailed information was described in Supplementary Materials and Methods, available at Carcinogenesis Online.
In vivo tumorigenicity assay
The in vivo tumorigenicity assay was depicted in Supplementary Materials and Methods, available at Carcinogenesis Online.
In vivo metastasis assay
The in vivo metastasis assay was depicted in Supplementary Materials and Methods, available at Carcinogenesis Online.
RNA interference
Three small interference RNAs (siRNAs) were purchased from Ribobio, Guangzhou. The target sequences were demonstrated in the Supplementary Materials and Methods, available at Carcinogenesis Online.
Real-time polymerase chain reaction and western blotting
Real-time polymerase chain reaction and western blots were performed as previously described (12) . Detailed information was listed in Supplementary Tables 1 and 2 , available at Carcinogenesis Online.
Fluorescence microscopy
The procedures of fluorescence microscopy were shown in the Supplementary Materials and Methods, available at Carcinogenesis Online.
Tissue microarray (TMA) construction
A TMA block was constructed as previously described (13) . Detailed information was shown in the Supplementary Materials and Methods, available at Carcinogenesis Online.
Immunohistochemical staining
Immunohistochemistry protocols were performed as described previously (11) . Detailed information was depicted in the Supplementary Materials and Methods, available at Carcinogenesis Online.
Statistical analyses
The results were analyzed using SPSS 22.0 software for Windows (IBM). The statistical analyses were performed using chi-squared test, student's t-test and analysis of variance (ANOVA). P < 0.05 was considered statistically significant. The clinicopathological features in each group were compared using Pearson's χ 2 test for categorical variables. Survival analysis was performed using Kaplan-Meier method. The correlation between ATP1A1 and CA2 was analyzed with Pearson's χ 2 test. * indicates P < 0.05, ** indicates P < 0.01.
Results
CA2 is inversely correlated with ATP1A1 in HCC
In our previous study, we showed that downregulation of ATP1A1 in Hep3B cell results in reduced cell migration (12) . In the present study, we confirm the metastatic role of ATP1A1 using another HCC cell line SMMC-7721. To examine the function of ATP1A1 in HCC, ATP1A1 knockdown SMMC-7721 cells were established using shRNA (Supplementary Figure 1A , Figure 1D and 1E, available at Carcinogenesis Online). Orthotropic xenograft models were used to corroborate the metastasis-promoting capability of ATP1A1. Detailed observation revealed that intrahepatic metastasis occurred in 100% (4/4) of the shRNA-NC group and in 75% (3/4) of the shRNA-ATP1A1 group. Pulmonary metastases were detected in 100% (4/4) of the shRNA-NC group whereas a lower incidence was observed in the shRNA-ATP1A1 group (75%, 3/4; Supplementary Figure 1F , available at Carcinogenesis Online). In our previous study, CA2 was significantly elevated in ATP1A1-downregulated HCC cells (12) . Therefore their correlation was further investigated in HCC. CA2 was significantly upregulated in ATP1A1 shRNA-treated HCC cells whereas it was downregulated in ATP1A1-overexpressed-SMMC-7721 cells ( Figure 1A ). RT-PCR showed the decreased CA2 and elevated ATP1A1 expression in HCC samples ( Figure 1B Western blot and immunohistochemistry showed that CA2 was significantly downregulated in HCC (Figure 1Cand 1D ). The present results of CA2 expression in tumor and adjacent tissues were consistent with those of studies as analyzed by The Cancer Genome Atlas (TCGA) ( Figure 1E ). Spearman correlation analysis demonstrated that CA2 mRNA was inversely correlated with ATP1A1 mRNA in HCC ( Figure 1F ). The correlation between ATP1A1 and CA2 was further analyzed by immunohistochemistry, which confirmed the inverse correlation between ATP1A1 and CA2 in HCC ( Figure 1G ). We also examined the prognostic significance of CA2 and ATP1A1 in HCC patients. Kaplan-Meier revealed that higher ATP1A1 expression was associated with decreased overall survival (OS) whereas increased CA2 expression significantly improved OS ( Figure 1H) . Besides, the association of ATP1A1 and CA2 expression with the clinicopathological features of HCC was evaluated (Supplementary Table 3 , available at Carcinogenesis Online). Univariate analysis showed that gender, vascular invasion, metastasis status and CA2 were factors influencing OS. Multivariate analysis demonstrated CA2 as an independent prognostic factor in HCC (Table 1) . Taken together, these data indicated that CA2 is inversely correlated with ATP1A1 and serves as a prognostic parameter in HCC. performed three times and representative data are shown. * P < 0.05, ** P < 0.01.
CA2 suppresses tumorigenesis and metastasis in HCC
Because CA2 was identified as a survival indicator in HCC patients, its role was further assessed. CA2-overexpressing HCC cells were generated (Supplementary Figure 3, available at Carcinogenesis Online) and its role in cell proliferation was tested. Results showed that CA2 inhibited proliferation (Figure 2A and B) . Next, its role in invasion and metastasis was explored. CA2 attenuated the invasive and metastatic ability of HCC cells ( Figure 2C and D) . Results also showed that CA2 has remarkably inhibited tumor growth in subcutaneous tumor models. Tumor volumes were smaller and tumor weight was lower in mice injected with CA2-overexpressing cells than in those injected with vector ( Figure 2E ). In orthotopic xenograft model, intrahepatic and pulmonary metastases were also significantly fewer in CA2-overexpressing mice than in control mice. Intrahepatic metastasis occurred in 100% (8/8) of the vector group and in 75% (6/8) of the CA2-overexpression group. Pulmonary metastases occurred in all mice in the vector group whereas only half (50%, 1/2) of mice developed lung metastasis in the CA2-overxpression group ( Figure 2F ). Altogether, these findings suggest that CA2 suppresses tumorigenesis and metastasis in HCC.
CA2 knockdown promotes proliferation, migration and invasion in HCC
Because CA2 inhibited HCC migration and invasion, its role was also examined in HCC cells. CA2 was downregulated successfully in HCC cells using CA2 siRNA (Supplementary Figure 4 , available at Carcinogenesis Online and Figure 3A ). CA2-downregulated HCC cells showed enhanced proliferation ( Figure 3B and C) . Transwell showed that their metastatic and invasive ability was higher than in NC siRNA-treated cells ( Figure 3D and E). Taken together, these results corroborated that CA2 serves as a suppressor of HCC metastasis.
CA2 inhibits EMT in SMMC-7721 cells
Our results identified CA2 as a suppressor of HCC metastasis. Considering that EMT is the hallmark of tumor metastasis, we examined CA2's effect on EMT. Morphological observation showed that vector cells included spindle-shaped cells whereas CA2-overexpressing cells were pebble-alike ( Figure 4A ). CA2 downregulation significantly promoted EMT in SMMC-7721 cells whereas CA2 overexpression inhibited EMT ( Figure 4B and C) . Besides, the fluorescence intensity of E-cadherin was enhanced in CA2-overexpressing cells and weakened in vector cells. N-cadherin and vimentin intensities were increased in vector cells ( Figure 4D ). Assessment of F-actin, a protein associated with metastatic capability showed thin fiber-like filaments in control cells whereas CA2-overexpressing cells showed dotted distribution ( Figure 4D ). These results indicated that CA2 inhibit EMT in HCC cells.
CA2 is involved in ATP1A1-induced metastasis and invasion in HCC
To further verify CA2's function in ATP1A1-induced HCC metastasis, rescue experiments were performed. CA2 downregulation facilitated cell proliferation in shRNA-NC and shRNA-ATP1A1cells. CA2 overexpression rescued ATP1A1 proliferation-promoting effect, which was also validated by clone formation ( Figure 5A and B). CA2 downregulation exacerbated the metastatic and invasive capabilities whereas CA2 overexpression had the opposite effect ( Figure 5C and D). CA2 overexpression inhibited tumor growth in shRNA-ATP1A1 and vector groups. The tumor volumes and tumor weights of each group are shown in Figure 5E .
CA2 is inversely correlated with ATP1A1 and EMTrelated markers in HCC
We tested the expressions of CA2, ATP1A1 and EMT markers in HCC samples. Immunohistochemistry showed that HCC patients with lower CA2 expressions had higher levels of ATP1A1 and EMT markers whereas patients with higher CA2 expressions had reduced ATP1A1 and EMT-related marker levels ( Figure 6A ). Their expressions were examined in HCC patients using TMA, which revealed the inverse relationship between CA2 and ATP1A1, EMT markers ( Figure 6A) . Furthermore, the mRNA expressions of ATP1A1, CA2, E-cadherin, Vimentin were also measured in tumor tissues from a cohort of 74 patients.
Results have shown the positive correlation between CA2 and E-cadherin and the inverse relationship between CA2 and ATP1A1, Vimentin ( Figure 6B ). . Statistical significance (P < 0.05) is indicated with Vector1+Vector2 (*), and (P < 0.01) is indicated with Vector1+Vector2 ( ** ). All experiments were performed three times and representative data are shown. * P < 0.05, ** P < 0.01.
Discussion
CA2, an isoform of the CA family, functions in the reversible hydration-dehydration of carbon dioxide. The abnormal expression of CA2 is associated with many diseases, such as cardiomyocyte hypertrophy and autoimmune diseases (3-6) and its relevance in cancer has recently been highlighted (14, 15 ). CA2's role in cancers depends on the tumor type. For instance, CA2 is overexpressed and serves as a useful biomarker in gastrointestinal stromal tumors (GISTs) diagnosis (16) . However, CA2 inhibits cancer cell growth in colorectal cancer (17) . In urinary bladder cancers, CA2 is an invasion-associated element (18) . The role of CA2 in HCC remains unclear. A previous study showed that CA2 is downregulated in HCC and associated with HCC tumor growth and metastasis, despite the unclear mechanisms. Previously, we showed that CA2 is upregulated in ATP1A1-downregulated HCC cells (12) . Therefore in this study, we examined their roles and associations in HCC. We showed their inverse relationship in HCC. CA2 was downregulated and ATP1A1 was upregulated in HCC. HCC patients with higher CA2 and lower ATP1A1levels had longer OS, suggesting their prognostic values in HCC.
NKA, is an ion transport pump that plays a vital role in the maintenance of the homeostasis of Na + and K + and cell physiology (7, 8) . As cancer is often accompanied by metabolic disorders, NKA, as an active pump using energy from ATP, is closely associated with tumor progression (18, 19) . Its overexpression is associated with esophageal squamous cell carcinoma and glioblastoma (10, 11) . ATP1A1 inhibition in glioblastoma triggers actin cytoskeleton reorganization and cytotoxic proautophagic effects, which are linked with decreased cell migration and proliferation (11) .
Recently, one study attributed the tumor-promoting role of ATP1A1 in HCC to cellular responses to stress, DNA repair and metabolism (12) . Another study reported that NKA inhibition led to S-phase cell cycle block through the downregulation of AURKA, CDK1 and Cyclin D expression, and that NKA reduction could attenuate NUMA1, SMC2 and TPX2 expression, resulting in chromosome segregation disorders (20) . Moreover, the SFK pathway, Src, EGF receptor, ERK1/2, AKT and caveolin-1 were related to ATP1A1 (21) (22) (23) (24) .
In this study, we demonstrated the metastasis-facilitating effect of ATP1A1 and its inverse association with CA2 in HCC metastasis. CA2 overexpression was associated with improved OS in HCC in contrast to that of ATP1A1, which led us to examine its role in HCC. CA2 inhibited invasion and metastasis of HCC as determined by functional studies, and the metastatic ability was enhanced by CA2 knockdown. These results indicated that CA2 reversed tumor metastasis in HCC.
EMT is widely acknowledged as an indispensable player in tumor metastasis (25) . Tumor cells shift from epithelial features to mesenchymal characteristics during the EMT process to acquire more metastatic abilities (26) . Moreover, the actin cytoskeleton may also undergo remodeling in tumor cells, changing from organized thin bundles to thick stress fibers (27) . Cells with CA2 downregulation showed suppressed epithelial marker expression concomitant with increased mesenchymal marker expression whereas CA2 overexpressing cells showed opposite pattern. In the control cells, actin showed a stress fiber-like morphology, indicating the potential for invasion and metastasis. However, CA2 overexpression has disturbed the normal cytoskeleton to dotted and irregular shape, which may have a migration-inhibiting effect.
Previous studies demonstrated that CA2 and NKA cooperate to regulate ion transport (28) . During choroid plexus development, the levels of NKA and CA2 are low to ensure proper colony stimulating factor secretion early in brain development (29) . Furthermore, the coexistence of NKA, CA2 and vacuolar H-ATPase is vital for the proper function of the gills of freshwater adult lampreys (30) . However, the association between ATP1A1 and CA2 in HCC tumor progression has not been reported to date. In this study, we centered on CA2's role in ATP1A1-induced HCC invasion and metastasis considering their relationship in HCC. Therefore, rescue experiments were further performed. In vitro studies showed that CA2 not only attenuated ATP1A1-triggered HCC proliferation but also suppressed the migration and invasion induced by ATP1A1. In vivo experiments showed that CA2 overexpression abolished ATP1A1-induced tumor growth. Altogether, these results indicated that CA2 is involved in ATP1A1-induced invasion and metastasis in HCC.
The correlation between CA2 and ATP1A1 needs to be further explored. In our study, we demonstrated that CA2 acts as a downstream of ATP1A1 and contributes to ATP1A1-induced tumor metastasis. However, the role of ATP1A1 in HCC metastasis is a comprehensive result of all the effects combined. Therefore, CA2 may contribute partially to ATP1A1-triggered HCC metastasis. The interactions between CA2 and ATP1A1 may be complex and warrant our further study.
In summary, the present study elucidated a novel role of CA2 in HCC metastasis. We provided the first evidence that CA2 is involved in ATP1A1-induced HCC metastasis. Our study provides information t for the development of targeted therapies aimed at preventing metastasis in HCC patients at early stages.
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